Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model

BACKGROUND: Debio 1143, a potent orally available SMAC mimetic, targets inhibitors of apoptosis proteins (IAPs) members and is currently in clinical trials. In this study, nuclear imaging evaluated the effects of Debio 1143 on tumor cell death and metabolism in a triple-negative breast cancer (TNBC)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Contrast Media Mol Imaging
Main Authors: Bellaye, Pierre-Simon, Oudot, Alexandra, Vrigneaud, Jean-Marc, Raguin, Olivier, Bichat, Francis, Vaslin, Anne, Maby-El Hajjami, Hélène, Zanna, Claudio, Vuagniaux, Grégoire, Fumoleau, Pierre, Denat, Franck, Brunotte, François, Collin, Bertrand
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305031/
https://ncbi.nlm.nih.gov/pubmed/30627061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8494031
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares